![Steffen Heeger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steffen Heeger
Hoofd Techniek/Wetenschap/O&O bij
ACTINIUM PHARMACEUTICALS, INC.
Vermogen: 172 332 $ op 30-09-2026
Profiel
Steffen Heeger is Chief Medical Officer at Actinium Pharmaceuticals, Inc. since 2026.
Former positions include Head-Clinical Development at MorphoSys AG, Head-Medical Affairs at Merck Serono SA, Chief Medical Officer at Ryvu Therapeutics SA, and Chief Medical Officer at Shanghai Full-Life Technologies Co., Ltd. Education includes a doctorate from Ruprecht-Karls-Universität Heidelberg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 03-09-2026 | 153.868 ( 0,49% ) | 172 332 $ | 30-09-2026 |
Actieve functies van Steffen Heeger
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2026 |
Eerdere bekende functies van Steffen Heeger
| Bedrijven | Functie | Einde |
|---|---|---|
Shanghai Full-Life Technologies Co. Ltd.
 Shanghai Full-Life Technologies Co. Ltd. BiotechnologyHealth Technology Engages in radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients | Hoofd Techniek/Wetenschap/O&O | - |
| RYVU THERAPEUTICS S.A. | Hoofd Techniek/Wetenschap/O&O | - |
Merck Serono SA
 Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Corporate Officer/Principal | - |
| MORPHOSYS AG | Corporate Officer/Principal | - |
Opleiding van Steffen Heeger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Ryvu Therapeutics SA
 Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Shanghai Full-Life Technologies Co. Ltd.
Shanghai Full-Life Technologies Co. Ltd. BiotechnologyHealth Technology Engages in radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients | Health Technology |
